Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery

Recurrent and metastatic thyroid cancer is more invasive and can transform to dedifferentiated thyroid cancer, thus leading to a severe decline in the 10-year survival. The thyroid-stimulating hormone receptor...

Source: BMC Endocrine Disorders - May 19, 2023 Category: Endocrinology Authors: Xue Yang, Yonglin Wu, Shaojie Xu, Hanning Li, Chengcheng Peng, Xiaoqing Cui, Deenraj Kush Dhoomun, Ge Wang, Tao Xu, Menglu Dong, Xingrui Li and Yaying Du Tags: Research Source Type: research